Cummock, J.S.; Haider, A.J.; Kazmi, M.; Haque, W.M.; Farach, A.M.; Butler, E.B.; Teh, B.S.
Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial. Cancers 2026, 18, 352.
https://doi.org/10.3390/cancers18030352
AMA Style
Cummock JS, Haider AJ, Kazmi M, Haque WM, Farach AM, Butler EB, Teh BS.
Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial. Cancers. 2026; 18(3):352.
https://doi.org/10.3390/cancers18030352
Chicago/Turabian Style
Cummock, Jonathon S., Ali J. Haider, Mohummad Kazmi, Waqar M. Haque, Andrew M. Farach, E. Brian Butler, and Bin S. Teh.
2026. "Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial" Cancers 18, no. 3: 352.
https://doi.org/10.3390/cancers18030352
APA Style
Cummock, J. S., Haider, A. J., Kazmi, M., Haque, W. M., Farach, A. M., Butler, E. B., & Teh, B. S.
(2026). Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial. Cancers, 18(3), 352.
https://doi.org/10.3390/cancers18030352
